Dutosme, Herminia S.
HRN: 01-03-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/01/2024
05/08/2024
IV
600mg
Q8
Infected Wound
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes